Skip to content

Neuroscan

Country not established

Devices
3

What Neuroscan makes

Neuroscan manufactures electrophysiological recording systems, including the NUAMPS and SYNAMPS2 for EEG and evoked potential studies, as well as the QUIK-CAP for electrode application and positioning.

These devices are classified as Class II under FDA regulations and are authorised via the 510(k) pathway. The company is based in the United States.

AI-generated from registry data, 1 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue3

Newest first, rows 1-3 of 3

  • Nuamps Ref K023536

    Active Regimes: 510(k) Registry: 510(k) Class:II

  • SYNAMPS2 Ref K023771

    Active Regimes: 510(k) Registry: 510(k) Class:II

  • Quik-Cap Ref K000865

    Active Regimes: 510(k) Registry: 510(k) Class:II

Frequently asked questions

How many devices does Neuroscan have in the registry?

The registry currently lists 3 devices for Neuroscan. Devices recorded under merged duplicate company entries are counted once.

Which registries list Neuroscan's devices?

Among its 3 most recently registered devices, Neuroscan has devices listed in FDA 510(k) (3 devices).

What risk classes do Neuroscan's devices fall under?

Among its 3 most recently registered devices, the classes recorded for Neuroscan's devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Neuroscan in the registry?

The most recently registered devices listed for Neuroscan include NUAMPS, SYNAMPS2 and QUIK-CAP.

Generated automatically from registry data and not verified by a human reviewer.